Advanced Biomedical Research

Interaction of Sex Hormones and the Renin–Angiotensin System in Ovariectomized Rats Subjected to Ischemia-Reperfusion Induction

Authors

Department of Physiology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

Abstract

Backgrounds: Ischemia-reperfusion (IR) injuries occur in a variety of clinical conditions, which lead to kidney damage. Most of the tissue damages after IR are due to the activation of the renin–angiotensin system (RAS). Hence, in this study, the interaction of sex hormones and RAS in ovariectomized (OV) rats subjected to IR induction has been studied. Materials and Methods: The animals were divided into different groups. Groups 1 (OV + E, OV rat + estradiol) and 2 (OV rat) each one consisted of three separate IR-induced subgroups treated with losartan, angiotensin 1–7 (Ang 1–7), and their combination, Group 3, as control and Group 4, as sham. Next, 72 h after IR, blood samples were collected, the right kidneys were homogenized, and left kidneys were fixed in 10% formalin. Results: Findings show that serum blood urea nitrogen, creatinine, and kidney tissue damage score levels increased significantly with induction of IR (P < 0.05). Mean serum levels of these factors in OV + E groups are higher than those of the OV. The presence or absence of estradiol did not affect the levels of antioxidants in the different groups receiving Los, Ang 1–7, and their combination. Los, Ang 1–7, and their combination reduced serum and kidney malondialdehyde levels in both OV and OV + E groups. Conclusion: Estrogen not only fails to improve renal functioning but it can also exacerbate it. While the treatments used in this study, in the absence of estradiol, it had a better effect on kidney damages and improved its functions.

Keywords

1.
Hassoun HT, Grigoryev DN, Lie ML, Liu M, Cheadle C, Tuder RM, et al. Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol 2007;293:F30-40.  Back to cited text no. 1
    
2.
Robert R, Ghazali DA, Favreau F, Mauco G, Hauet T, Goujon JM. Gender difference and sex hormone production in rodent renal ischemia reperfusion injury and repair. J Inflamm (Lond) 2011;8:14.  Back to cited text no. 2
    
3.
Sullivan JC. Sex and the renin-angiotensin system: Inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol 2008;294:R1220-6.  Back to cited text no. 3
    
4.
Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002;53:672-7.  Back to cited text no. 4
    
5.
Chappell MC, Diz DI, Yunis C, Ferrario CM. Differential actions of angiotensin-(1-7) in the kidney. Kidney Int Suppl 1998;68:S3-6.  Back to cited text no. 5
    
6.
de Groot H, Rauen U. Ischemia-reperfusion injury: Processes in pathogenetic networks: A review. Transplant Proc 2007;39:481-4.  Back to cited text no. 6
    
7.
Slegtenhorst BR, Dor FJ, Rodriguez H, Voskuil FJ, Tullius SG. Ischemia/reperfusion injury and its consequences on immunity and inflammation. Curr Transplant Rep 2014;1:147-54.  Back to cited text no. 7
    
8.
Owonikoko TK, Fabucci ME, Brown PR, Nisar N, Hilton J, Mathews WB, et al. In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT1) receptor expression by PET. J Nucl Med 2004;45:94-100.  Back to cited text no. 8
    
9.
Borrás C, Gambini J, López-Grueso R, Pallardó FV, Viña J. Direct antioxidant and protective effect of estradiol on isolated mitochondria. Biochim Biophys Acta 2010;1802:205-11.  Back to cited text no. 9
    
10.
Safari T, Nematbakhsh M, Evans RG, Denton KM. High-dose estradiol-replacement therapy enhances the renal vascular response to angiotensin II via an AT2-receptor dependent mechanism. Adv Pharmacol Sci 2015;2015:682745.  Back to cited text no. 10
    
11.
Forte BL, Slosky LM, Zhang H, Arnold MR, Staatz WD, Hay M, et al. Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. Pain 2016;157:2709-21.  Back to cited text no. 11
    
12.
Ghadirian F, Nematbakhsh M, Roozbehani S, Mazaheri S, Talebi A, Pezeshki Z, et al. Nonprotective role of losartan in cisplatin-induced nephrotoxicity in ovariectomized rat model treated with estradiol. J Pharm Negat Results 2015;6:2.  Back to cited text no. 12
    
13.
Iran-Nejad A, Nematbakhsh M, Eshraghi-Jazi F, Talebi A. Preventive role of estradiol on kidney injury induced by renal ischemia-reperfusion in male and female rats. Int J Prev Med 2015;6:22.  Back to cited text no. 13
[PUBMED]  [Full text]  
14.
Miri S, Safari T, Komeili GR, Nematbakhsh M, Niazi AA, Jahantigh M, et al. Sex difference in gentamicin-induced nephrotoxicity: Influence of L-arginine in rat model. Int J Prev Med 2018;9:108.  Back to cited text no. 14
    
15.
Safari T, Nematbakhsh M, Miri S, Ghofran O, Fereidooni F, Niazi AA, et al. Gender differences in response to Vitamin E and C in gentamicin induced nephrotoxicity in Wistar rats. J Nephropathol 2017;6:338-345.  Back to cited text no. 15
    
16.
Saberi S, Dehghani A, Nematbakhsh M. Role of mas receptor in renal blood flow response to angiotensin-(1-7) in ovariectomized estradiol treated rats. Res Pharm Sci 2016;11:65-72.  Back to cited text no. 16
    
17.
Xu P, Costa-Goncalves AC, Todiras M, Rabelo LA, Sampaio WO, Moura MM, et al. Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice. Hypertension 2008;51:574-80.  Back to cited text no. 17
    
18.
Rabello Casali K, Ravizzoni Dartora D, Moura M, Bertagnolli M, Bader M, Haibara A, et al. Increased vascular sympathetic modulation in mice with mas receptor deficiency. J Renin Angiotensin Aldosterone Syst 2016;17:1-16.  Back to cited text no. 18
    
19.
da Silveira KD, Pompermayer Bosco KS, Diniz LR, Carmona AK, Cassali GD, Bruna-Romero O, et al. ACE2-angiotensin-(1-7)-mas axis in renal ischaemia/reperfusion injury in rats. Clin Sci (Lond) 2010;119:385-94.  Back to cited text no. 19
    
20.
Batlle D, Wysocki J, Soler MJ, Ranganath K. Angiotensin-converting enzyme 2: Enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy. Kidney Int 2012;81:520-8.  Back to cited text no. 20
    
21.
Qi Y, Zhang J, Cole-Jeffrey CT, Shenoy V, Espejo A, Hanna M, et al. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension 2013;62:746-52.  Back to cited text no. 21
    
22.
Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev 2015;4:20-7.  Back to cited text no. 22
    
23.
Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: Potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol 2001;280:F365-88.  Back to cited text no. 23
    
24.
Li L, Ji H, Holloway C, Sandberg K, Ecelbarger C. Effects of 17β-estradiol replacement in a model of renal ischemia in the ovariectomized female apolipoprotein E knockout mouse (1135.2). FASEB J 2014;28 Suppl 1:1135.2.  Back to cited text no. 24
    
25.
Gross ML, Adamczak M, Rabe T, Harbi NA, Krtil J, Koch A, et al. Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol 2004;15:348-58.  Back to cited text no. 25
    
26.
Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol 1993;45:509-11.  Back to cited text no. 26
    
27.
Takaoka M, Yuba M, Fujii T, Ohkita M, Matsumura Y. Oestrogen protects against ischaemic acute renal failure in rats by suppressing renal endothelin-1 overproduction. Clin Sci (Lond) 2002;103 Suppl 48:434S-7S.  Back to cited text no. 27
    
28.
Saberi S, Dehghani A, Nematbakhsh M. Angiotensin 1-7 administration increases renal blood flow in the absence of bradykinin B2 receptor in ovariectomized estradiol treated rats: The role of mas receptor. Acta Med Iran 2019;57 (2):103-109.  Back to cited text no. 28
    
29.
Higashi Y, Sanada M, Sasaki S, Nakagawa K, Goto C, Matsuura H, et al. Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 2001;37:651-7.  Back to cited text no. 29
    
30.
Lu W, Kang J, Hu K, Tang S, Zhou X, Yu S, et al. Angiotensin-(1-7) relieved renal injury induced by chronic intermittent hypoxia in rats by reducing inflammation, oxidative stress and fibrosis. Braz J Med Biol Res 2017;50:e5594.  Back to cited text no. 30
    
31.
Fang F, Liu GC, Zhou X, Yang S, Reich HN, Williams V, et al. Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury. PLoS One 2013;8:e71433.  Back to cited text no. 31
    
32.
Nematbakhsh M, Safari T. Role of mas receptor in renal blood flow response to angiotensin (1-7) in male and female rats. Gen Physiol Biophys 2014;33:365-72.  Back to cited text no. 32
    
33.
Armando I, Jezova M, Juorio AV, Terrón JA, Falcón-Neri A, Semino-Mora C, et al. Estrogen upregulates renal angiotensin II AT (2) receptors. Am J Physiol Renal Physiol 2002;283:F934-43.  Back to cited text no. 33
    
34.
Silva-Antonialli MM, Tostes RC, Fernandes L, Fior-Chadi DR, Akamine EH, Carvalho MH, et al. Alower ratio of AT1/AT2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats. Cardiovasc Res 2004;62:587-93.  Back to cited text no. 34
    
35.
Srisawat U, Kongrat S, Muanprasat C, Chatsudthipong V. Losartan and sodium nitroprusside effectively protect against renal impairments after ischemia and reperfusion in rats. Biol Pharm Bull 2015;38:753-62.  Back to cited text no. 35
    
Advanced Biomedical Research
Volume 2019, october
October 2019
Pages 1-7